Current Pharmaceutical Biotechnology
Title:Subject Index To Volume 3
Volume: 4 Issue: 1
Author(s):
Affiliation:
Export Options
About this article
Cite this article as:
, Subject Index To Volume 3, Current Pharmaceutical Biotechnology 2003; 4 (1) . https://dx.doi.org/10.2174/1389201033378002
DOI https://dx.doi.org/10.2174/1389201033378002 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
10
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Glycerophospholipid Synthesis as a Novel Drug Target Against Cancer
Current Molecular Pharmacology Insulin Therapy for Diabetes Epidemic: A Patent Review
Current Drug Delivery Surface Modified Nanoparticulate Carrier Constructs for Oral Mucosal Vaccine Delivery
Current Drug Delivery Growth Arrest Specific Gene (GAS) 6 Modulates Platelet Thrombus Formation and Vascular Wall Homeostasis and Represents an Attractive Drug Target
Current Pharmaceutical Design On the Physiological Role of Cytosolic 5’-nucleotidase II (cN-II): Pathological and Therapeutical Implications.
Current Medicinal Chemistry Combination of Anti-EGFR Drugs and Other Molecular Targeted Agents as Anti-Cancer Strategy
Current Cancer Therapy Reviews Subject Index to Volume 4
Current Medicinal Chemistry - Anti-Cancer Agents Calixarene: A Versatile Material for Drug Design and Applications
Current Pharmaceutical Design Functional Peptides and Small Molecules in Medicinal Chemistry-Part I
Current Topics in Medicinal Chemistry A Simplified Protocol Employing Elacridar in Rodents: A Screening Model in Drug Discovery to Assess P-gp Mediated Efflux at the Blood Brain Barrier
Drug Metabolism Letters An Overview on Screening Methods for Lysine Specific Demethylase 1 (LSD1) Inhibitors
Current Medicinal Chemistry Rationale and Design of the CAN Study: an RCT of Survival after Propofol- or Sevoflurane-based Anesthesia for Cancer Surgery
Current Pharmaceutical Design Targeting the Epidermal Growth Factor Receptor in Glioblastoma Treatment
Current Signal Transduction Therapy Novel Patents and Cancer Therapies for Transforming Growth Factor- Beta and Urokinase Type Plasminogen Activator: Potential Use of Their Interplay in Tumorigenesis
Recent Patents on Anti-Cancer Drug Discovery Demystifying the ACE Polymorphism: From Genetics to Biology
Current Pharmaceutical Design Current Strategies and Future Directions for Eluding Adenoviral Vector Immunity
Current Gene Therapy Post-Wortmannin Era: Novel Phosphoinositide 3-Kinase Inhibitors with Potential Therapeutic Applications
Current Enzyme Inhibition Combining Radiation and Cancer Gene Therapy: A Potential Marriage of Physical and Biological Targeting?
Current Cancer Drug Targets Novel Drug Targets in Malaria Parasite with Potential to Yield Antimalarial Drugs with Long Useful Therapeutic Lives
Current Pharmaceutical Design Diagnosis of Pathogens Using DNA Microarray
Recent Patents on Biotechnology